PDF(Pubmed)
Abstract：
UNASSIGNED: The novel Coronavirus is belonging to the family of SARS & MERS-CoV, the impact of the earlier is more dreadful as demonstrated by the steady increase in morbid cases. The average incubation period of COVID-19 is 1-14 days with a mean of 6 days. Aim - To evaluate predictors of mortality among COVID-19 patients. Objectives - 1. To assess risk predictors associated with mortality among COVID-19 patients 2. To a suggest prediction model for preventing mortality in future outbreaks.
UNASSIGNED: Study design - A case-control study. Study place -Tertiary care center, Nanded, Maharashtra. The present study included 400 cases that died off due to Covid-19 and 400 controls survived COVID-19 disease in a 1:1 proportion.
UNASSIGNED: On admission, a significant difference was observed among cases and controls with reference to the percentage of SpO2 (p < 0.05). The proportion of associated co-morbidities among cases was very high i.e., 75.75% as compared to controls with a proportion of 29.25% co-morbidities. The median days of hospital stay were significantly lower in cases compared to controls (3 days vs 12 days, P < 0.001).
UNASSIGNED: Length of hospital stay (in days) was showing a significant difference among cases and control (3 days Vs 12 days); hospital stay was less (median 3 days) for cases, as they reported late and thus died earlier; hence concluded that early hospital admission will decrease chances of death due to COVID-19.
UNASSIGNED: Study design - A case-control study. Study place -Tertiary care center, Nanded, Maharashtra. The present study included 400 cases that died off due to Covid-19 and 400 controls survived COVID-19 disease in a 1:1 proportion.
UNASSIGNED: On admission, a significant difference was observed among cases and controls with reference to the percentage of SpO2 (p < 0.05). The proportion of associated co-morbidities among cases was very high i.e., 75.75% as compared to controls with a proportion of 29.25% co-morbidities. The median days of hospital stay were significantly lower in cases compared to controls (3 days vs 12 days, P < 0.001).
UNASSIGNED: Length of hospital stay (in days) was showing a significant difference among cases and control (3 days Vs 12 days); hospital stay was less (median 3 days) for cases, as they reported late and thus died earlier; hence concluded that early hospital admission will decrease chances of death due to COVID-19.
摘要：
■新型冠状病毒属于SARS和MERS-CoV家族，较早的影响更为可怕，病态病例的稳步增加证明了这一点。COVID-19的平均潜伏期为1-14天，平均为6天。目的-评估COVID-19患者死亡率的预测因素。目标-1.评估与COVID-19患者死亡率相关的风险预测因子2。提出了预防未来疫情死亡的预测模型。
■研究设计-病例对照研究。研究地点-三级护理中心，Nanded,马哈拉施特拉邦.本研究包括400例因新冠肺炎死亡的病例和400例对照以1：1的比例在新冠肺炎疾病中存活。
■入学时，在SpO2百分比方面，病例和对照组之间观察到显着差异（p<0.05）。病例中相关合并症的比例非常高，即与具有29.25%合并症的比例的对照相比,75.75%。与对照组相比，病例的中位住院天数显着降低（3天vs12天，P<0.001)。
■住院时间（以天为单位）在病例和对照组之间存在显着差异（3天比12天）；病例的住院时间较少（中位数为3天），因为他们报告较晚，因此死亡较早；因此得出结论，提前入院将减少因COVID-19死亡的机会。
■研究设计-病例对照研究。研究地点-三级护理中心，Nanded,马哈拉施特拉邦.本研究包括400例因新冠肺炎死亡的病例和400例对照以1：1的比例在新冠肺炎疾病中存活。
■入学时，在SpO2百分比方面，病例和对照组之间观察到显着差异（p<0.05）。病例中相关合并症的比例非常高，即与具有29.25%合并症的比例的对照相比,75.75%。与对照组相比，病例的中位住院天数显着降低（3天vs12天，P<0.001)。
■住院时间（以天为单位）在病例和对照组之间存在显着差异（3天比12天）；病例的住院时间较少（中位数为3天），因为他们报告较晚，因此死亡较早；因此得出结论，提前入院将减少因COVID-19死亡的机会。
